- ICH GCP
- US Clinical Trials Registry
- Search trials
Search clinical trials for: fractionated rituximab
Total 2542 results
-
National Cancer Institute (NCI)RecruitingAnn Arbor Stage II Diffuse Large B-Cell Lymphoma | Ann Arbor Stage III Diffuse Large B-Cell Lymphoma | Ann Arbor Stage IV Diffuse Large B-Cell Lymphoma | AIDS-Related LymphomaUnited States
-
University Hospital MuensterDeutsche Krebshilfe e.V., Bonn (Germany)RecruitingMature B-cell Non-Hodgkin LymphomaAustria, Czechia, Denmark, Finland, Germany, Norway, Sweden, Switzerland
-
University of CambridgeUniversity of OxfordRecruitingPsychosis | Autoimmune EncephalitisUnited Kingdom
-
M.D. Anderson Cancer CenterNational Cancer Institute (NCI)RecruitingRecurrent Adult Lymphoblastic Lymphoma | Recurrent High Grade B-Cell Lymphoma With MYC and BCL2 or BCL6 Rearrangements | Refractory High Grade B-Cell Lymphoma With MYC and BCL2 or BCL6 Rearrangements | Recurrent Acute Lymphoblastic Leukemia | Refractory Acute Lymphoblastic Leukemia | Recurrent... and other conditionsUnited States
-
Baylor College of MedicineThe Methodist Hospital Research Institute; Center for Cell and Gene Therapy...RecruitingT-cell Acute Lymphoblastic Leukemia | T-cell Acute Lymphoblastic Lymphoma | T-non-Hodgkin LymphomaUnited States
-
Shanghai Chest HospitalRecruiting
-
Cellectar Biosciences, Inc.RecruitingMultiple Myeloma | Waldenstrom Macroglobulinemia | Mantle Cell Lymphoma | Marginal Zone Lymphoma | Chronic Lymphocytic Leukemia | Lymphoplasmacytic Lymphoma | Diffuse Large B Cell Lymphoma | Small Lymphocytic Lymphoma | Central Nervous System LymphomaUnited States, Australia, Czechia, Greece, Israel, Brazil, Finland, France, Spain, Turkey, United Kingdom
-
M.D. Anderson Cancer CenterNational Cancer Institute (NCI)RecruitingB Acute Lymphoblastic Leukemia | B Lymphoblastic LymphomaUnited States
-
Prof. Dr. M. Dreyling (co-chairman)LMU KlinikumRecruitingMantle Cell LymphomaGermany, Sweden, Denmark, Italy, Norway
-
St. Jude Children's Research HospitalRecruitingAcute Myeloid Leukemia (AML) | Acute Lymphoblastic Leukemia (ALL) | Myelodysplastic Syndrome (MDS) | Myeloid Sarcoma | Chronic Myeloid Leukemia (CML) | Non-Hodgkin Lymphoma (NHL) | Juvenile Myelomonocytic Leukemia (JMML)United States
-
Asan Medical CenterCheolwon SuhRecruitingDiffuse Large B Cell LymphomaKorea, Republic of
-
M.D. Anderson Cancer CenterNational Cancer Institute (NCI)RecruitingRecurrent Hodgkin Lymphoma | Chronic Myelomonocytic Leukemia | Previously Treated Myelodysplastic Syndrome | Recurrent Adult Acute Myeloid Leukemia | Acute Lymphoblastic Leukemia | Secondary Acute Myeloid Leukemia | Myelodysplastic Syndrome | Recurrent Acute Myeloid Leukemia | Myelodysplastic Syndrome... and other conditionsUnited States
-
Technical University of MunichHelmholtz Zentrum MünchenRecruiting
-
Diagram B.V.Johnson & Johnson; Biosense Webster, Inc.RecruitingChronic Atrial FibrillationFrance, Netherlands, Japan
-
Samsung Medical CenterRecruitingPeripheral T-cell LymphomaKorea, Republic of
-
Canadian Cancer Trials GroupRoche Pharma AG; Janssen, LP; Karyopharm Therapeutics IncRecruiting
-
Nilratan Sircar Medical CollegeRecruiting
-
National Cancer Institute (NCI)RecruitingMultiple Myeloma | Hodgkin's Lymphoma | Non-Hodgkin's Lymphoma | Acute Leukemia | Myelodysplastic SyndromeUnited States
-
Sir Mortimer B. Davis - Jewish General HospitalRecruitingPatients With Symptomatic or Bulky Tumors (More Than 8 cm) or With Tumors Resistant to RadiationCanada
-
Memorial Sloan Kettering Cancer CenterPharmacyclics LLC.; Janssen Biotech, Inc.RecruitingAdult Patients With Newly Diagnosed or Relapsed or Refractory Primary Central Nervous System Lymphoma (PCNSL) | Or Relapsed or Refractory Secondary Central Nervous System Lymphoma (SCNSL)United States
-
National Cancer Institute (NCI)RecruitingPrimary Central Nervous System LymphomaUnited States
-
Seoul National University HospitalRecruitingRheumatoid Arthritis | Psoriatic Arthritis | Ankylosing SpondylitisKorea, Republic of
-
Proton Collaborative GroupRecruitingProstate CancerUnited States
-
M.D. Anderson Cancer CenterNational Cancer Institute (NCI)RecruitingAnn Arbor Stage I Grade 1 Follicular Lymphoma | Ann Arbor Stage I Grade 2 Follicular Lymphoma | Ann Arbor Stage II Grade 1 Follicular Lymphoma | Ann Arbor Stage II Grade 2 Follicular LymphomaUnited States
-
National Cancer Institute (NCI)RecruitingKSHV Inflammatory Cytokine Syndrome (KICS) | KSHV | HHV-8United States
-
M.D. Anderson Cancer CenterNational Cancer Institute (NCI)RecruitingRecurrent B Acute Lymphoblastic Leukemia | Refractory B Acute Lymphoblastic Leukemia | B Acute Lymphoblastic Leukemia, Philadelphia Chromosome Negative | B Acute Lymphoblastic Leukemia With t(9;22)(q34.1;q11.2); BCR-ABL1 | Recurrent Burkitt Lymphoma | Refractory Burkitt Lymphoma | High Grade B-Cell... and other conditionsUnited States
-
National Institute of Diabetes and Digestive and...RecruitingProteinuria | Nephrotic Syndrome | Autoimmune Disease | Glomerular Disease | Membranous GlomerulonephritisUnited States
-
Paul SzabolcsRecruiting
-
M.D. Anderson Cancer CenterNational Cancer Institute (NCI)RecruitingHairy Cell Leukemia | Recurrent Hairy Cell LeukemiaUnited States
-
AstraZenecaActive, not recruitingUntreated Chronic Lymphocytic LeukemiaThailand, Vietnam, Philippines, China, Taiwan
-
Janssen Research & Development, LLCPharmacyclics LLC.Active, not recruitingLymphoma, Mantle-CellTaiwan, Thailand, Malaysia, India, Puerto Rico, Spain, Turkey, Czechia, Brazil, Greece, Poland, Sweden, Romania
-
Alliance for Clinical Trials in OncologyNational Cancer Institute (NCI)SuspendedB Acute Lymphoblastic LeukemiaUnited States, Canada
-
Gilead SciencesThe Leukemia and Lymphoma SocietyTerminatedNon Hodgkin LymphomaUnited States, Australia, United Kingdom
-
Hoffmann-La RocheActive, not recruitingLymphoma, Large B-Cell, DiffuseUnited States, France, Spain, Italy
-
Novartis PharmaceuticalsActive, not recruitingRelapsing Multiple SclerosisUnited States, Puerto Rico
-
Weill Medical College of Cornell UniversityAstraZeneca; Celgene CorporationActive, not recruitingMantle Cell LymphomaUnited States
-
Memorial Sloan Kettering Cancer CenterUniversity of Michigan; Weill Medical College of Cornell University; Janssen...Active, not recruiting
-
National Cancer Institute (NCI)Active, not recruitingStage I Chronic Lymphocytic Leukemia | Stage II Chronic Lymphocytic Leukemia | Stage III Chronic Lymphocytic Leukemia | Stage IV Chronic Lymphocytic LeukemiaUnited States, Canada
-
Fondazione Italiana Linfomi - ETSRoche Pharma AGWithdrawnDiffuse Large B-cell Lymphoma Recurrent | Diffuse Large B Cell Lymphoma RefractoryItaly
-
National Cancer Institute (NCI)Active, not recruitingAnemia | Chronic Lymphocytic Leukemia | Small Lymphocytic LymphomaUnited States
-
National Cancer Institute (NCI)Active, not recruitingAnn Arbor Stage II Diffuse Large B-Cell Lymphoma | Ann Arbor Stage III Diffuse Large B-Cell Lymphoma | Ann Arbor Stage IV Diffuse Large B-Cell LymphomaUnited States
-
National Cancer Institute (NCI)Active, not recruitingDiffuse Large B-Cell Lymphoma | High Grade B-Cell Lymphoma With MYC and BCL2 or BCL6 Rearrangements | Diffuse Large B-Cell Lymphoma, Not Otherwise Specified | Double-Expressor Lymphoma | EBV-Positive Diffuse Large B-Cell Lymphoma, Not Otherwise Specified | High Grade B-Cell Lymphoma, Not Otherwise... and other conditionsUnited States
-
Debiopharm International SACompletedDiffuse Large B-Cell Lymphoma | B-cell Non-Hodgkin's LymphomaUnited States, Czechia, Bulgaria, Belgium, Hungary, Ukraine, Italy, Poland, Switzerland
-
AbbVieCompleted
-
National Institute of Diabetes and Digestive and...Completed
-
National Cancer Institute (NCI)Active, not recruitingAnn Arbor Stage III Non-Hodgkin Lymphoma | Ann Arbor Stage IV Non-Hodgkin Lymphoma | Ann Arbor Stage II Non-Hodgkin LymphomaUnited States
-
National Cancer Institute (NCI)Active, not recruitingBurkitt Lymphoma | Primary Mediastinal Large B-cell Lymphoma | Gray Zone Lymphoma | Diffuse Large B-Cell Lymphoma (DLBCL) | Anaplastic Large-Cell LymphomaUnited States
-
M.D. Anderson Cancer CenterNational Cancer Institute (NCI)Active, not recruitingMantle Cell LymphomaUnited States
-
National Cancer Institute (NCI)Active, not recruitingHairy Cell LeukemiaUnited States
-
National Cancer Institute (NCI)Active, not recruitingHIV | Lymphoproliferative Disorder | Malignancy | HHV-8United States